Results 311 to 320 of about 289,858 (341)
Genetic Variants of <i>UGP2</i> and <i>FBP2</i> in the Glycolysis Pathway Independently Predict Survival of Patients with HBV-Related Hepatocellular Carcinoma. [PDF]
J Hepatocell CarcinomaGong R +16 more
europepmc +1 more source
Mitochondrial genomic alterations in cholangiocarcinoma cell lines. [PDF]
PLoS OneFaipan A +11 more
europepmc +1 more source
Sorafenib with or without co-interventions for hepatocellular carcinoma. [PDF]
Cochrane Database Syst RevChen S, Liu JP, Li X, Dang S, Li W.
europepmc +1 more source
Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy. [PDF]
J Hepatocell CarcinomaZheng X, Qian K.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Hepatology, 2012
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural history of the tumor and the development of staging systems that stratify patients according to the characteristics of the tumor, the liver disease, and the ...
Alejandro Forner +4 more
openaire +2 more sources
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal neoplasia, the management of which has significantly improved during the last few years. A better knowledge of the natural history of the tumor and the development of staging systems that stratify patients according to the characteristics of the tumor, the liver disease, and the ...
Alejandro Forner +4 more
openaire +2 more sources
Reviews on Recent Clinical Trials, 2008
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with increasing incidence in the Western World. In contrast to most other malignancies, only surgical and local ablative therapeutic options have shown efficacy in patients with HCC. Systemic chemotherapy has failed to show a substantial benefit for these patients.
Tim F. Greten +2 more
openaire +3 more sources
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide with increasing incidence in the Western World. In contrast to most other malignancies, only surgical and local ablative therapeutic options have shown efficacy in patients with HCC. Systemic chemotherapy has failed to show a substantial benefit for these patients.
Tim F. Greten +2 more
openaire +3 more sources
Abdominal Imaging, 2011
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Ángeles García-Criado +2 more
openaire +2 more sources
Imaging techniques play a crucial role in the management of patients with liver cirrhosis in whom a nodular hepatic lesion is detected. The most severe complication of patients with liver cirrhosis is the development of a hepatocellular carcinoma (HCC), and the prognosis of the disease depends on the tumoral stage.
Ángeles García-Criado +2 more
openaire +2 more sources
Biochemical Genetics, 2023
Racial/ethnic and region disparities in incidence and mortality are obviously in liver cancer. Mongolia has the highest reported incidence and mortality of hepatocellular carcinoma (HCC) in the world, while the incidence of HCC is relatively low in the United States, but differences in their molecular characteristics remain largely elusive.
Rui, Huang +6 more
openaire +2 more sources
Racial/ethnic and region disparities in incidence and mortality are obviously in liver cancer. Mongolia has the highest reported incidence and mortality of hepatocellular carcinoma (HCC) in the world, while the incidence of HCC is relatively low in the United States, but differences in their molecular characteristics remain largely elusive.
Rui, Huang +6 more
openaire +2 more sources